CFO
PBH icon

Callan Family Office’s Prestige Consumer Healthcare PBH Stock Holding History

Callan Family Office’s Portfolio PBH Stock Details PBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$548K Buy
11,584
+2,918
+34% +$150K 0.01% 786
2026
Q1 		$514K Buy
+8,666
New +$562K 0.01% 759
2025
Q3 		– Sell
-7,083
Closed -$566K – 923
2025
Q2 		$566K Buy
+7,083
New +$592K 0.02% 551

Other funds holding PBH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Callan Family Office's PBH Position: Q2 2026 in Review

Callan Family Office increased its Prestige Consumer Healthcare (PBH) stake by 34% in Q2 2026, buying an estimated $150K and bringing the position to 11,584 shares worth $548K. The position accounts for 0.01% of the portfolio, ranked #786.

Callan Family Office first reported a position in PBH in Q2 2025 and has held it in 3 quarters since. The position peaked at $566K in Q2 2025. 318 funds tracked by Wall St. Rank hold PBH as of Q2 2026.

  • Callan Family Office held 11,584 shares of Prestige Consumer Healthcare worth $548K as of Q2 2026.
  • Callan Family Office bought 2,918 Prestige Consumer Healthcare shares in Q2 2026, an estimated $150K.
  • Prestige Consumer Healthcare made up 0.01% of Callan Family Office's portfolio in Q2 2026, its #786 holding.
  • Callan Family Office first reported a position in Prestige Consumer Healthcare in Q2 2025 and has held it in 3 quarters since.
  • Callan Family Office's Prestige Consumer Healthcare position peaked at $566K in Q2 2025.
  • 318 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.

Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.